Iran deal stupidest of all time, Trump says

October 21, 2016

Jeddah, Oct 21: Leading experts in Arab affairs, columnists and journalists feel that the race for the American presidential elections remains wide open and evenly poised.

trump2

They described the outcome of the three presidential debates as inconclusive and unclear.

For some, Hillary Clinton came out on top; for others Donald Trump, despite his brashness, managed to retain his appeal to his core base of voters.

For Faisal Al-Yafai, chief columnist at the Abu Dhabi-based The National newspaper, watching the three debates, gave one a sense of what he called the vibrancy and pageantry of American democracy.

“That has its pros and cons. The vibrancy is that you see so many people, tens of millions of people, watching three debates of 90-minute each. Which is fantastic. The downside is that it is really about the public performance of politics rather than real politics or real policies. Which is a shame.”

He said there was no doubt that Clinton had come across as more presidential.

“To her credit, she has managed to deal with Trump in a way that no Republican contender could. You have to give her enormous credit for that. None of the Republican contenders was able to land a blow on him, but Clinton managed to do that in the three debates,” he said.

However, he adds a word of caution.

“I don't think you can count Trump out yet because, I think, the debates were important to some parts of America but not to all parts. Those people who like Trump genuinely like Trump. They don't really care what comes across in the debate. To them, the debates are just part of what they consider the mainstream media and the establishment,” he said.

So who does Al-Yafai think will win? “It is still unknown who will win. Clinton is, in my opinion, very far ahead. But, as I said, the people who like Trump will vote for him regardless of what the media says or the establishment says. His supporters don't care about his nastiness. They care about their candidate. Not only will they not believe what was said during the debates, the negative commentary, etc., they will go out in substantial numbers to vote for him.”

Al-Yafai said whoever became the president of America, it matters to the Middle East because of America's influence in the region.

“Most Middle East watchers probably on balance prefer Clinton because she is a known quantity in the way that Trump is not. At the same time, the issues that most Middle Eastern countries have with the United States go far beyond one particular candidate, one particular party or one particular president. I think Clinton would be better at handling some of the difficulties that the region faces. We look to the Americans to be partners with us on the big challenges of the Middle East, such as Syria, Yemen and Iraq. With that in mind, we would prefer Clinton.”

But, he said, Clinton is only the best of what is on offer. “There has not been a presidential candidate that I have seen yet who understands the relationship that America needs with the Middle East and the relationship that Arabs deserve with America.”

His verdict: “You can't count Trump out yet.”

Very precise but despised

For Raghida Dergham, New York-based columnist and bureau chief for Al-Hayat pan-Arab publication, Clinton is very scripted, very organized and very precise which is what she should be if she is running for such an office.

“Trump thinks it is all right to simply change the rules for the debates. It is very embarrassing to witness such name-calling in a debate for such a high office. I have watched earlier debates from 20 and 30 years ago and I saw people discuss policies. These debates are more of a show than an opportunity to debate matters of importance,” she told Arab News.

She does not think that the debates have won any supporters for Clinton from among those who do not like her to begin with.

“People despise her for being part of the establishment. They do not trust her. There are strong feelings against her by many people. I don't think she came out of the debate in any way that will change the minds of those who are already sure of where they stand,” she said. “Clinton was, however, probably effective with those who are undecided and who are looking for something that will sway them one way or another.”

Through the debates, she showed that she has the temperament to lead rather than just to react and be amusing or different. “She projected that she could be in the White House and take on this big responsibility,” said Dergham. “Those who dislike her are going to say she did not do a good job in the past so why should we believe her now? Those who are opposed to Clinton are not only opposed to Clinton, they are opposed to the (Obama) administration.”

Dergham said she was very disturbed by Trump's “simple-mindedness” when it comes to Middle Eastern issues that are of concern to the world.

“The way he speaks about Russian President Vladimir Putin is frightening because he does not look at the actions of Russia in the region. He is only focused on saying from his point of view who won, who lost. He thinks the Russians have won, the (Obama) administration has lost. I mean both — Russia and the Obama administration — have contributed to the misery of what is going on in Syria. But it is really offensive that Trump looks at this as who won and who lost when so many people are dying and suffering and when there is so much human tragedy.”

As somebody from the region, Dergham has multiple concerns. “I am concerned about Trump's approach to all the people of the Middle East as well as to Muslims and to immigrants. I am disturbed by his dismissal of people en masse. I don't think he is going to reset Obama's administration's policies. Clinton will try to reset ties with the Gulf countries, probably because she knows it is time to reset the relationship. Trump will play outside the rules and not inside them. That would probably lead some to say it is time to do that because playing by the rules, we only got where we did not want to be in Syria and in Mosul both of which are a catastrophe.”

Don't count Trump out

So who won the debates? For Dergham, “Those who love Trump, love his brash approach; they love his facial expressions and they love that he called Clinton “a nasty woman.” They are the voters who are decided. With the undecided, I think, Clinton won the last debate.”

Her verdict: “The race is still open. It is always open until the last minute. You can never tell what surprises might come up. I think there could be a major event that might change things. It is always open until the votes are counted.”

Abeer Mishkhas, London-based Saudi journalist with Asharq Al-Awsat newspaper, felt Wednesday night's debate improved Clinton's chances because “Trump couldn't get beyond his style of attacking and demeaning her. On the other hand, she was calm. She was in control. She was very statesmanly, or rather, states-womanly. She presented a very good argument for being president of the United States.”

She said whenever Trump talks about a foreign country, one gets the feeling that he is unaware of foreign policy issues and of how foreign policy is conducted.

“Trump takes a very simplistic view of how things are done. He talks about Putin and he says, ‘He likes me.' He doesn't know what he is talking about. Compare this to Clinton who served as secretary of state. She knows exactly what constitutes foreign policy. She has the experience and she seems clear about what she is going to do.”

Mishkhas does not like a couple of things about Clinton. “For instance, I don't agree with her passive stand on the Palestinian issue. As US secretary of state, she was always pro-Israel. She did not support the Palestinians during their most difficult times when they were basically being massacred.”

She thinks Clinton might be tempted to go to war with Iran to demonstrate American might and to show that America is a superpower.

“She is just the way she is. She would gladly go to war with Iran just to prove that she is as tough as anyone else,” said Mishkhas.

She feels Clinton did not do well in the previous two debates. “I don't know who instructed her to keep smiling. That did not give the correct impression of her. It seemed as if she was not ready. She took Trump lightly and talked about petty issues. She should have concentrated on policies and what exactly she wants to do. In Debate 3 on Wednesday night, however, she came out on top.”

Her verdict: “It is very hard to tell because when you listen to Trump supporters, they seem happy with what he is doing. They are the people who are not going to be influenced by TV debates anyway. It is very tricky. The race is still wide open.”

For Dr. Khaled Al-Shoqran, head of the Al-Rai Center for Strategic Studies in Amman, Clinton was the clear winner. “I think Clinton did better. She is fully aware of political and international issues. Trump is unacceptable because he knows very little about things outside the United States he said.

“Clinton has a good vision and she has good ideas for solving Middle Eastern problems. She is very vocal on Iraq, Syria and Yemen which is good,” he said. “She has a plan and she will be very successful as president of the United States. She did very well in all three debates.”

His verdict: “Clinton is far ahead.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 2,2020

Washington, Jun 2: There is no place for hate and racism in the society, Microsoft CEO Satya Nadella has said, asserting that empathy and shared understanding are a start, but more needs to be done. Nadella’s remarks come in the wake of the custodial death of George Floyd, a 46-year-old African-American man who was pinned to the ground in Minneapolis on May 25 by a white police officer who kneeled on his neck as he gasped for breath.

“There is no place for hate and racism in our society. Empathy and shared understanding are a start, but we must do more,” Nadella said in a tweet on Monday.

“I stand with the Black and African American community and we are committed to building on this work in our company and in our communities,” Nadella said.

A day earlier, Google CEO Sunder Pichai expressed solidarity with the African-American community.

“Today on US Google & YouTube homepages we share our support for racial equality in solidarity with the Black community and in memory of George Floyd, Breonna Taylor, Ahmaud Arbery & others who don’t have a voice,” Pichai wrote on Twitter on Sunday.

“For those feeling grief, anger, sadness & fear, you are not alone,” Pichai said, sharing a screenshot of the Google search home page which said, “We stand in support of racial equality, and all those who search for it.”

Nadella’s Microsoft also said they will be using the platform to amplify voices from the Black and African American community at the company.

Nadella had also spoken out a few months ago about the discriminatory Citizenship Amendment Act passed in his native country. Talking to BuzzFeed’s editor-in-chief, Ben Smith, in Manhattan, Nadella said what’s happening in the country is “sad.”

“I think what is happening is sad. I feel, and in fact quite frankly, now being informed (and) shaped by the two amazing American things that I’ve observed which is both, it’s technology reaching me where I was growing up and its immigration policy and even a story like mine being possible in a country like this.

“I think, it’s just bad, if anything, I would love to see a Bangladeshi immigrant who comes to India and creates the next unicorn in India or becomes the CEO of Infosys. That should be the aspiration. If I had to sort of mirror what happened to me in the US, I hope that’s what happens in India,” Microsoft’s India-born CEO was quoted as saying by BuzzFeed.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 15,2020

May 15: Global tensions simmered over the race for a coronavirus vaccine Thursday, as the United States and China traded jabs, and France slammed pharmaceuticals giant Sanofi for suggesting the US would get any eventual vaccine first.

Scientists are working at breakneck speed to develop a vaccine for COVID-19, the disease caused by the virus, which has killed more than 300,000 people worldwide and pummelled economies.

From the US to Europe to Asia, national and local governments are easing lockdown orders to get people back to work -- while fretting over a possible second wave of infections.

Increased freedom of movement means an increased risk of contracting the virus, and so national labs and private firms are labouring to find the right formula for a vaccine.

The European Union's medicines agency offered some hope when it said one could be ready in a year, based on data from clinical trials already underway.

But Marco Cavaleri, the EMA's head of vaccines strategy, acknowledged that timeline was a "best-case scenario," and cautioned that "there may be delays."

The race for a vaccine has exposed a raw nerve in relations between the United States and China, where the virus was first detected late last year in the central city of Wuhan.

Two US agencies warned Wednesday that Chinese hackers were trying to steal COVID-19 vaccine research -- a claim Beijing rejected as "smearing" its reputation.

US President Donald Trump, who has ratcheted up the rhetoric against China, said he doesn't even want to engage with Chinese leader Xi Jinping -- potentially imperilling a trade deal between the world's top two economies.

"I'm very disappointed in China. I will tell you that right now," he said in an interview with Fox Business.

"There are many things we could do. We could do things. We could cut off the whole relationship."

On Capitol Hill, an ousted US health official told Congress that the Trump government had no strategy in place to find and distribute a vaccine to millions of Americans, warning of the "darkest winter" ahead.

"We don't have a single point of leadership right now for this response, and we don't have a master plan," said Rick Bright, who was removed last month as head of the US agency charged with developing a coronavirus vaccine.

The United States has registered nearly 86,000 deaths linked to COVID-19 -- the highest toll of any nation.

World leaders were among 140 signatories to a letter published Thursday saying any vaccine should not be patented and that the science should be shared among nations.

"Governments and international partners must unite around a global guarantee which ensures that, when a safe and effective vaccine is developed, it is produced rapidly at scale and made available for all people, in all countries, free of charge," it said.

But a row erupted in France after drugmaker Sanofi said it would reserve first shipments of any vaccine it discovered to the United States.

The comments prompted a swift rebuke from the French government -- President Emmanuel Macron's office said any vaccine should be treated as "a global public good, which is not submitted to market forces."

Sanofi chief executive Paul Hudson said the US had a risk-sharing model that allowed for manufacturing to start before a vaccine had been finally approved -- while Europe did not.

"The US government has the right to the largest pre-order because it's invested in taking the risk," Hudson told Bloomberg News.

Macron's top officials are scheduled to meet with Sanofi executives about the issue next week.

The search for a vaccine became even more urgent after the World Health Organization said the disease may never go away and the world would have to learn to live with it for good.

"This virus may become just another endemic virus in our communities and this virus may never go away," said Michael Ryan, the UN body's emergencies director.

The prospect of the disease lingering leaves governments facing a delicate balancing act between suppressing the pathogen and getting their economies up and running.

In the US, more grim economic data emerged Thursday, with nearly three million more Americans applying for unemployment benefits.

That takes the overall total to 36.5 million -- more than 10 percent of the US population.

Further signs of the damage to businesses emerged when Lloyd's of London forecast the pandemic will cost the global insurance industry about $203 billion.

European markets closed down, but Wall Street rallied despite the new jobless claims. In a sign of progress, the New York Stock Exchange trading floor was due to reopen on May 26.

The reopening of economies continued in earnest across Europe, where the EU has set out proposals for a phased restart of travel and the eventual lifting of border controls.

"Maybe it's a mistake, but we have no choice. Without tourists, we won't get by!" Enrico Facchetti, a 61-year-old former goldsmith, said of Venice's reopening.

Japan -- the world's third largest economy -- lifted a state of emergency across most of the country except for Tokyo and Osaka.

And Canadian Prime Minister Justin Trudeau said national parks would partially reopen on June 1.

But in Latin America, the virus continued to surge, with a 60 percent leap in cases in the Chilean capital of Santiago.

Authorities said 2,000 new graves were being dug at the main cemetery.

South Sudan reported its first COVID-19 death on Thursday.

And in Bangladesh, the first case was confirmed in the teeming Rohingya refugee camps in Bangladesh, which are home to nearly one million people.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.